An accident on a school trip resulted in a diagnosis of kidney cancer for a teacher
Sarah, a patient from the KCSN, spoke on BBC Radio Humberside on [...]
Our love pulls us through the dark days: the impact of kidney cancer on our lives
The Harborough Mail ran a front page story featuring Rebecca and James [...]
Soraya Vivian: KCSN Ambassador for World Kidney Cancer Day 2018
We are delighted that singer-songwriter Soraya Vivian has agreed to [...]
Prognostic biomarkers for the management of kidney cancer
In this article, Dr Daniel Heng focuses on prognostic criteria [...]
Cognitive behavioural therapy compared to acupuncture for insomnia
A recent study compared cognitive behavioural therapy (CBT) with acupuncture [...]
Kidney cancer vaccine abandoned after failure of phase 3 clinical trial
Argos Therapeutics has abandoned its phase 3 trial of rocapuldencel-T (a [...]
Axitinib fails as an adjuvant therapy for high risk kidney cancer
The phase 3 ATLAS clinical trial to assess axitinib as [...]
European Medicines Agency approves 4-week dosing schedule for nivolumab
The Committee for Medicinal Products for Human Use (CHMP) of [...]
Adjuvant sunitinib declined by European Medicines Agency committee
The Committee for Medicinal Products for Human Use (CHMP) of [...]
Combination therapies for kidney cancer
The following is a Practice Update interview with Dr Hans Hammers, Associate [...]
